367 related articles for article (PubMed ID: 28513001)
1. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study.
Simpson AC; Schissler JR; Rosychuk RAW; Moore AR
Vet Dermatol; 2017 Oct; 28(5):485-e113. PubMed ID: 28513001
[TBL] [Abstract][Full Text] [Related]
2. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
3. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
[TBL] [Abstract][Full Text] [Related]
4. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Walsh KF; Follis SI; King VI; Tena JK; Stegemann MR
Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
[TBL] [Abstract][Full Text] [Related]
5. Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study.
Peterson AL; Torres SM; Rendahl A; Koch SN
Vet Dermatol; 2012 Jun; 23(3):201-e43. PubMed ID: 22409401
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Martin DD; Walsh KF; Harfst JA; Follis SL; King VL; Boucher JF; Stegemann MR
Vet Dermatol; 2013 Oct; 24(5):479-e114. PubMed ID: 23829933
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
Marsella R; Ahrens K
Vet Dermatol; 2018 Oct; 29(5):439-e146. PubMed ID: 29926994
[TBL] [Abstract][Full Text] [Related]
9. Frequency of urinary tract infection among dogs with pruritic disorders receiving long-term glucocorticoid treatment.
Torres SM; Diaz SF; Nogueira SA; Jessen C; Polzin DJ; Gilbert SM; Horne KL
J Am Vet Med Assoc; 2005 Jul; 227(2):239-43. PubMed ID: 16047659
[TBL] [Abstract][Full Text] [Related]
10. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
Ortalda C; Noli C; Colombo S; Borio S
Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
[TBL] [Abstract][Full Text] [Related]
11. Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.
Visser M; Walsh K; King V; Sture G; Caneva L
BMC Vet Res; 2022 Mar; 18(1):103. PubMed ID: 35300697
[TBL] [Abstract][Full Text] [Related]
12. The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study.
Rynhoud H; Croton C; Henry G; Meler E; Gibson JS; Soares Magalhaes RJ
BMC Vet Res; 2022 Apr; 18(1):151. PubMed ID: 35477466
[TBL] [Abstract][Full Text] [Related]
13. Pilot evaluation of Enterococcus faecium SF68 as adjunctive therapy for oclacitinib-responsive adult atopic dermatitis in dogs.
Yamazaki C; Rosenkrantz W; Griffin C
J Small Anim Pract; 2019 Aug; 60(8):499-506. PubMed ID: 31257599
[TBL] [Abstract][Full Text] [Related]
14. The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.
Levy BJ; Linder KE; Olivry T
Vet Dermatol; 2019 Jun; 30(3):201-e63. PubMed ID: 31006925
[TBL] [Abstract][Full Text] [Related]
15. Prolonged twice-daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client-owned atopic dogs.
Denti D; Caldin M; Ventura L; De Lucia M
Vet Dermatol; 2022 Apr; 33(2):149-e42. PubMed ID: 35014745
[TBL] [Abstract][Full Text] [Related]
16. Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.
Panteri A; Strehlau G; Helbig R; Prost C; Doucette K
Vet Dermatol; 2016 Feb; 27(1):22-e7. PubMed ID: 26660461
[TBL] [Abstract][Full Text] [Related]
17. An update on the treatment of canine atopic dermatitis.
Saridomichelakis MN; Olivry T
Vet J; 2016 Jan; 207():29-37. PubMed ID: 26586215
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI.
Segev G; Sykes JE; Klumpp DJ; Schaeffer AJ; Antaki EM; Byrne BA; Yaggie RE; Westropp JL
J Vet Intern Med; 2018 Jan; 32(1):267-273. PubMed ID: 29243301
[TBL] [Abstract][Full Text] [Related]
19. Urinary tract infections in dogs with spontaneous hypercortisolism - frequency, symptoms and involved pathogens.
Dupont P; Burkhardt W; Boretti F; Riond B; Reusch C; Willi B; Sieber-Ruckstuhl N
Schweiz Arch Tierheilkd; 2020 Jul; 162(7):439-450. PubMed ID: 32618567
[TBL] [Abstract][Full Text] [Related]
20. Bacterial urinary tract infection and subclinical bacteriuria in dogs receiving antineoplastic chemotherapy.
Harrer J; Fejös C; Zablotski Y; Hirschberger J; Wolf G; Rieger A; Mayer C; Dorsch R
J Vet Intern Med; 2022 May; 36(3):1005-1015. PubMed ID: 35524488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
